The academic to founder pipeline with Dr. Stacy Blain from Concarlo Therapeutics
Welcome back to Found, where we get the stories behind the startups. This week, Becca and Dom are joined by Stacy Blain, the co-founder and chief science officer at Concarlo Therapeutics. Blain talked
11 investors predict a colorful, if difficult, future for psychedelic startups
How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look.
Cortical Labs raises $10M for its Pong-playing stem cells that eventually could power AI
While generative AI is buzzy right now, what OpenAI, Microsoft and Google are doing may be only part of the story. There is also the process of using biology: the idea of using stem cells to create bi
Curing disease with CRISPR with Trevor Martin from Mammoth Biosciences
Welcome back to Found, where we get the stories behind the startups. This week Darrell and Becca are joined by Trevor Martin the co-founder and CEO of Mammoth Biosciences, a startup that uses CRISPR t
Startup says the seaweed blobbing toward Florida has a silver lining
A brown macroalgae native to the Atlantic’s Sargasso Sea is increasingly a menace to coastal ecosystems and communities across the Gulf of Mexico, ever since mats of the normally beneficial seaw
This VC built a lab to make building biotech startups easier
When you think of life sciences and biotech hubs in the U.S., where do you travel to in your mind? Boston? The Bay Area? Texas? Portal Innovations, a biotech VC firm based in Chicago, is trying to bro
5 strategies for biotech startups to outlast a market downturn
To ensure survival, it’s essential to explore alternative funding methods rather than relying solely on classic fundraising.
TechCrunch+ roundup: Using predictive LTV, Boston VC survey, active learning for ML teams
Adding predictive LTV to your startup’s marketing strategy may literally help you stop throwing money away.
Biotech proved a surprisingly bright spot in 2022’s startup correction
While not totally immune to 2022's market correction, biotech fundraising proved to be more resilient than other sectors.
TechCrunch+ roundup: New VC rules, AI biotech investor survey, Instagram ad case study
"Growth at all costs" is a fairy tale made possible by cheap money that helped VCs set expectations for founders — and each other.
US sanctions on China could extend to biotech, official says
On the heels of the Biden administration’s decision to impose sweeping chip sanctions on China, there are signs that China might also lose access to other types of critical U.S. technologies, in
Solar Foods wants to replace industrial animal farming with a high-tech protein harvest
Fermentation has a long, rich history in food production, from beer and wine to yogurt and cheese, leavened bread and coffee, miso and tempeh, sauerkraut and kimchi, to name just a few of the tasty th
Breaking into healthcare with WELL Health and Freestyle on TechCrunch Live
Healthcare startups often face unique challenges — something Well Health founder Guillaume de Zwirek understands. Together with Freestyle Partner, Jenny Lefcourt, the two will speak on the strategie
Dioseve wants to help infertile people with tech that grows egg cells
Based in Japan, biotech startup Dioseve’s ambitious goal is to grow human oocytes, or eggs, from other tissue. Its aim is to help people struggling with infertility, and it recently raised $3 millio
Mawi launches a patch to track your heart health faster and in real time
If you’ve ever had the misfortune of needing continuous EKG monitoring, you’ve probably used a Holter monitor. It’s like carrying a 1980s walkman made of metal with a bunch of wires
Daily Crunch: Raba Partnership leads $2.1M seed round for African fintech startup Thepeer
Hello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.
Auxilius lands $10M to help biopharmas manage financial aspects of the clinical trial process
Many of us take prescription medication with little to no understanding of just how long it takes — or how much it costs — to get that drug to market. Conducting clinical trials of a given medicat
Why Felix Williams, who started a VC firm at 19, believes his youth gives him an advantage as an investor
Felix Williams is the founder and managing director of Lagomaj Capital. Since starting the St. Louis, Missouri-based venture capital firm soon after completing high school, 23-year-old Williams has ba
Steal this hot new summer look (it’s bacteria)
Bacterial secretions might dye your future wardrobe, and that’d be an improvement. That’s because textiles usually get their hues from toxic chemicals, and the resulting wastewater — laden w
New Zealand’s Humble Bee Bio is using bees to create bioplastics
Humble Bee Bio is on a mission to create a biodegradable alternative to plastics by synthesizing the biology of bees. While the New Zealand-based company is still at an early stage — it’s